Use of PDE7 inhibitors for the treatment of neuropathic pain

Details for Australian Patent Application No. 2006219643 (hide)

Owner Pfizer Limited

Inventors Kinloch, Ross Anderson; Cox, Peter; Maw, Graham Nigel

Agent Allens Arthur Robinson

Pub. Number AU-A-2006219643

PCT Pub. Number WO2006/092691

Priority 0504209.8 01.03.05 GB; 60/675,761 27.04.05 US

Filing date 16 February 2006

Wipo publication date 8 September 2006

International Classifications

A61K 31/527 (2006.01) - spiro-condensed

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/537 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61K 31/547 (2006.01) - spiro-condensed or forming part of bridged ring systems

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/092691 Priority application(s): WO2006/092691

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006219649-A lamp using a light emitting diode (LED) as a light source

2006219617-Winding device